impelneuropharma | Moving Medicine Forward
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-7,,qode-title-hidden,qode-child-theme-ver-1.0.0,qode-theme-ver-9.5,wpb-js-composer js-comp-ver-5.1.1,vc_responsive

Moving Medicine Forward

Impel is developing next-generation
therapeutics for CNS disorders

What We Do

Impel NeuroPharma has multiple drug-device combination products built upon its Precision Olfactory Delivery™ (POD™) nasal delivery platform. These new nasal drug delivery devices are intended to achieve superior biodistribution, bioavailability, and decreased dose-to-dose variability of both small molecules and biologic drugs in patients. We intend to continue developing combination products both internally and through pharmaceutical company partnerships for migraine, Alzheimer’s, Parkinson’s disease, and other promising indications.